ClinicalTrials.gg
WithdrawnNCT03421665Updated Oct 15, 2018

Evaluation of the Titan 3-D™ Wedge System

An observational study in Flat Foot, Lateral Column Lengthening and Medial Cuneiform Osteotomy, sponsored by Paragon 28. Withdrawn. Per ClinicalTrials.gov, last updated 2018-10-15.

Sponsored by Paragon 28 (part of Zimmer Biomet) · Observational

Why this study was withdrawn
Sponsor decided to pursue an alternative study prior to subject enrollment.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
0
Sex
All
01

Study summary

Evaluate clinical healing and radiographic maintenance of correction following an LCL procedure or medial cuneiform osteotomy (Cotton) at 6 months following the use of the TITAN 3-D™ Wedge. Subjects who receive one or more TITAN 3-D™ Wedges will obtain satisfactory levels of clinical healing and radiographic maintenance of correction at 6 months.

02

Conditions studied

  • Flat Foot
  • Lateral Column Lengthening
  • Medial Cuneiform Osteotomy

Browse trials for

Keywords

  • titanium wedge
  • Evans
  • Cotton
03

In context

Flatfoot

173 studies on the registry are indexed under Flatfoot; 44 are open to participants now.

Browse Flatfoot studies →

Lead sponsor

Paragon 28 is the lead sponsor of 8 studies on the registry; 1 is open to participants now.

First submitted before Paragon 28 became part of Zimmer Biomet.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will include males and females of all ages. Furthermore, it is likely that the majority of subjects enrolled in this study suffer from a flatfoot deformity; however, this study will not be restricted to only those diagnosed with flatfoot.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. The subject has foot pain/discomfort on the foot in question.
  2. The subject has activity limitations due to the foot in question.
  3. The subject agrees to comply with the requirements of the study and complete the study measures.
  4. The subject (or representative of the subject in the case of a minor) is willing and able to provide written .
  5. The subject plans on undergoing an LCL procedure and/or medial cuneiform osteotomy with a TITAN 3-D™ Wedge.

Exclusion criteria

Exclusion Criteria:

  1. The subject is pregnant.
  2. The subject had been previously sensitized to titanium.
  3. The subject is scheduled for a same day bilateral LCL procedure or medial cuneiform osteotomy procedure.
  4. The subject is not expected to complete the study according to the investigation plan.
  5. The subject has been deemed physiologically or psychologically inadequate by the enrolling physician.
  6. The subject is: a prisoner, unable to understand what participation in the study entails, mentally incompetent, a known abuser of alcohol and/or drugs or anticipated to be non-compliant.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
0 participants (actual)
Patient registry
No

Groups and cohorts

  • Titan 3-D Wedge System

    Subjects who receive one or more Titan 3D wedge(s).

    Device: Titan 3D Wedge System

Interventions

  • DeviceTitan 3D Wedge System

    Each subject will undergo an LCL procedure and/or medial cuneiform osteotomy with one or more TITAN 3-D™ Wedges. Ancillary fixation should be used in conjunction with each TITAN 3-D™ Wedge used. This surgical procedure will be performed as standard of care and is not part of the research procedures. Post-operative care and weight-bearing/activity restrictions will be at the discretion of the surgeon as part of their standard of care for the procedure.

06

What researchers measure

Primary outcomes

  1. Clinical Healing

    Evaluate clinical healing following an LCL procedure or medial cuneiform osteotomy (Cotton) at 6 months following the use of the TITAN 3-D™ Wedge. Clinical healing is defined as lack of pain over the osteotomy site.

    Time frame: 6 Months

  2. Radiographic Maintenance of Correction

    Evaluate radiographic maintenance of correction following an LCL procedure or medial cuneiform osteotomy (Cotton) at 6 months following the use of the TITAN 3-D™ Wedge. Radiographic maintenance of correction is defined as the absence of a clinically relevant change in radiographic measures across post-operative time points.

    Time frame: 6 Months

Secondary outcomes

  1. Time to clinical/radiographic healing (union)

    Evaluate time to clinical/radiographic healing (union vs. non-union) after a Titan 3D wedge procedure

    Time frame: 24 Months

  2. Clinical complications

    Complications due to the procedure

    Time frame: 24 Months

  3. Maintenance of implant position

    Time frame: 24 Months

  4. Maintenance of anatomical alignment

    Time frame: 24 Months

  5. Determine bone reaction, if any, to the device such as overgrowth or cystic lesions

    Time frame: 24 Months

  6. Determine rate of removal of the device and subsequent healing

    Time frame: 24 Months

  7. Change in anatomical and radiographic angular/positional alignment before and after an LCL procedure and/or medial cuneiform osteotomy using a TITAN 3-D™ Wedge

    Time frame: 24 Months

  8. Change in VAS Pain Score across multiple time points

    Visual Analog Scale (VAS). Line from 0 (no pain) to 10 (worst pain). Patient reported.

    Time frame: Pre-operatively, 2 weeks, 6 weeks, 12 weeks, 6 months, 12 months, 24 months

  9. Change in AOFAS Ankle-Hindfoot and/or Midfoot Score across multiple time points

    American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot clinical score. Pain: 0-40 points Function: 0-50 points Alignment: 0-10 points Total Score (sum): 0-100 points (higher score indicates better outcomes) American Orthopaedic Foot and Ankle Society (AOFAS) Midfoot clinical score. Pain: 0-40 points Function: 0-45 points Alignment: 0-15 points Total Score (sum): 0-100 points (higher score indicates better outcomes)

    Time frame: Pre-operatively, 2 weeks, 6 weeks, 12 weeks, 6 months, 12 months, 24 months

  10. Change in PROMIS Pain Intensity Score across multiple time points

    Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Intensity Score, Item Bank v1.0, SF 3a. Raw Score Range: 3 (no pain) to 15 (very severe pain)

    Time frame: Pre-operatively, 2 weeks, 6 weeks, 12 weeks, 6 months, 12 months, 24 months

  11. Change in PROMIS Mobility Score across multiple time points

    Patient-Reported Outcomes Measurement Information System (PROMIS) Mobility Score, Item Bank v2.0. Raw Score Range: 15 (high level of difficulty) to 120 (no difficulty)

    Time frame: Pre-operatively, 2 weeks, 6 weeks, 12 weeks, 6 months, 12 months, 24 months

  12. Change in PROMIS Pain Interference Score across multiple time points

    Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference Score, Item Bank v1.0, SF 6a. Raw Score Range: 6 (no interference) to 30 (high level of interference)

    Time frame: Pre-operatively, 2 weeks, 6 weeks, 12 weeks, 6 months, 12 months, 24 months

  13. Compare the outcomes and complication rates of TITAN 3-D™ Wedges with previously published outcomes of historical controls, allograft bone and autograft bone

    Time frame: 24 Months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 15, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03421665
Lead sponsor
Paragon 28
Responsible party
Sponsor
First posted
Feb 5, 2018
Start date
Jun 15, 2018 (estimated)
Primary completion
Sep 1, 2022 (estimated)
Completion
Sep 1, 2022 (estimated)
Last update
Oct 15, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion